Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Literature
1.
Cochat P, Koch Nogueira PC, Mahmoud A, Jamieson NV, Scheinman JI, Rolland MO (1999) Primary hyperoxaluria in infants: medical, ethical, and economic issues. J Pediatr 135:746–750PubMed
Metadata
Title
Reply to the letter from C. von Schnakenburg et al.
Authors
Choni Rinat
Danko Milosevic
Yaacov Frishberg
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 5/2003
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-003-1108-2

Other articles of this Issue 5/2003

Pediatric Nephrology 5/2003 Go to the issue

Original Article

Proteinuria in cubilin-deficient patients with selective vitamin B12 malabsorption

Original Article

Blood pressure relates to sodium taste sensitivity and discrimination in adolescents

Letter to the Editors

Reversible secondary pseudohypoaldosteronism

Editorial Commentary

The biochemical diagnosis of Gitelman disease and the definition of "hypocalciuria"

Letter to the Editors

Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1

Original Article

Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children